Latest Articles
AI-Driven Advances in Women's Health Diagnostics: Current Applications and Future Directions.
Background: Women's health has historically served as an incubator for major medical innovations yet often faces relative neglect in sustained funding and implementation. The rise of artificial intelligence (AI) and …
Published: Dec. 3, 2025, midnight
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ - MSN
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ MSN
Published: Dec. 2, 2025, 11:26 p.m.
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ - Yahoo News Canada
Sask. woman with endometriosis says diagnosis after 11 years was a ‘relief’ Yahoo News Canada
Published: Dec. 2, 2025, 11:23 p.m.
Lexington mother–daughter team pushes for faster endometriosis diagnosis and better care in Mass. - Yahoo
Lexington mother–daughter team pushes for faster endometriosis diagnosis and better care in Mass. Yahoo
Published: Dec. 2, 2025, 9:59 p.m.
Global shift towards imaging for endometriosis diagnosis highlighted in new IJGO study - FIGO.org
Global shift towards imaging for endometriosis diagnosis highlighted in new IJGO study FIGO.org
Published: Dec. 2, 2025, 5:25 p.m.
How invisible symptoms and provider bias delay endometriosis diagnosis - Contemporary OB/GYN
How invisible symptoms and provider bias delay endometriosis diagnosis Contemporary OB/GYN
Published: Dec. 2, 2025, 2:02 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - Morningstar
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence Morningstar
Published: Dec. 2, 2025, 2 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - PR Newswire
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence PR Newswire
Published: Dec. 2, 2025, 2 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Link copied to clipboard!